Di Dac Tran, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 3 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
4 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (408) 272-9228 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
California Medical Board record
Licence A52125 · Current
Licensed to practise in California · since 1993 · expires 2027-01-31 · University of Saigon Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$4,290 in 2024
Medicaid paid $4,290 for 823 billed services this clinician did in 2024, up to 103 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 59 | $3,204 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 55 | $494 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $453 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 15 | $139 |
| Short return visit (20+ min) | 682 | $0 |
| 2024 | 823 | 5 | 103 | $4,290 |
| 2023 | 1,095 | 8 | 85 | $7,280 |
| 2022 | 1,368 | 12 | 97 | $6,246 |
| 2021 | 1,350 | 13 | 87 | $9,548 |
| 2020 | 1,501 | 15 | 148 | $10,236 |
| 2019 | 2,191 | 17 | 161 | $9,476 |
| 2018 | 1,872 | 16 | 127 | $7,302 |
See the largest Medicaid services in earlier years
2023
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 68 | $3,572 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 37 | $1,644 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $1,114 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 75 | $635 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 12 | $119 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $119 |
| Skin test; tuberculosis, intradermal | 25 | $78 |
| Short return visit (20+ min) | 851 | $0 |
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 52 | $2,418 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 39 | $1,625 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 18 | $660 |
| Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use | 43 | $377 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 27 | $238 |
| Skin test; tuberculosis, intradermal | 63 | $204 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 22 | $179 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $179 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 17 | $139 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 13 | $119 |
| Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 12 | $109 |
| Short return visit (20+ min) | 1,041 | $0 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 91 | $4,403 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 51 | $2,002 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 116 | $962 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 12 | $866 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $412 |
| Skin test; tuberculosis, intradermal | 77 | $248 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 25 | $198 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 13 | $129 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 17 | $119 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 13 | $109 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 12 | $99 |
| Short return visit (20+ min) | 899 | $0 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 66 | $3,228 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 62 | $2,512 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 138 | $1,250 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 25 | $989 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 21 | $743 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 40 | $367 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 27 | $248 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 30 | $238 |
| Skin test; tuberculosis, intradermal | 46 | $144 |
| Short return visit (20+ min) | 944 | $140 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 15 | $139 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 13 | $119 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 63 | $2,554 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 56 | $2,112 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 171 | $1,458 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 34 | $1,113 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $448 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 29 | $340 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 22 | $321 |
| Skin test; tuberculosis, intradermal | 76 | $218 |
| Varicella virus vaccine (VAR), live, for subcutaneous use | 26 | $198 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 24 | $179 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 16 | $149 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 16 | $129 |
2018
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 42 | $1,574 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 32 | $1,278 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 36 | $1,202 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 71 | $556 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 50 | $496 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 45 | $446 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 38 | $377 |
| Varicella virus vaccine (VAR), live, for subcutaneous use | 34 | $337 |
| Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 33 | $327 |
| Pure tone audiometry (threshold); air only | 19 | $243 |
| Skin test; tuberculosis, intradermal | 48 | $174 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 14 | $139 |
Drugs they prescribed that Part D paid
$1,181
Pharmacies billed $1,181 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 88) in 2024. At or below the middle of the specialty; the typical pediatric medicine clinician is at 0%.
86 generic and fewer than 11 brand-name prescriptions · $1,181 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydroxyzine | 17 | $814 | $48 |
Year by year
| 2024 | 88 | 14 | 0% (0) | None | $1,181 |
| 2023 | 91 | 18 | 0% (0) | None | $4,620 |
| 2022 | 99 | 13 | 0% (0) | None | $2,953 |
| 2021 | 66 | None | 0% (0) | None | $880 |
| 2020 | 63 | 11 | 0% (0) | None | $1,508 |
| 2019 | 35 | 11 | 0% (0) | None | $4,495 |
| 2018 | 65 | None | 0% (0) | None | $1,014 |
| 2017 | 38 | None | 0% (0) | None | $843 |
| 2016 | 11 | None | 0% (0) | None | $388 |
| 2014 | 23 | None | 0% (0) | None | $435 |
| 2013 | 45 | 12 | 0% (0) | None | $2,050 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Hydroxyzine | 20 | $1,117 | $56 |
2022: 1 drug
| Hydroxyzine | 28 | $1,439 | $51 |
2018: 2 drugs
| Atenolol | 21 | $105 | $5 |
| Simvastatin | 12 | $65 | $5 |
2014: 1 drug
| Atenolol | 11 | $35 | $3 |
2013: 1 drug
| Atenolol | 12 | $45 | $4 |
Professional record
- NPI
- 1619965670
- Licence
- CA A52125California A52125: Current · expires 2027-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2395 Montpelier Dr, Unit 6, San Jose, CA, 95116
- NPI first listed
- 2005-10-12
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.